Credit Industriel ET Commercial Has $5.43 Million Holdings in Surgery Partners, Inc. $SGRY

Credit Industriel ET Commercial grew its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 33.4% in the second quarter, Holdings Channel.com reports. The institutional investor owned 244,112 shares of the company’s stock after buying an additional 61,111 shares during the quarter. Credit Industriel ET Commercial’s holdings in Surgery Partners were worth $5,427,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. PNC Financial Services Group Inc. lifted its stake in shares of Surgery Partners by 86.4% in the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock worth $28,000 after buying an additional 542 shares during the last quarter. AlphaQuest LLC lifted its position in Surgery Partners by 112.0% during the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock worth $25,000 after acquiring an additional 559 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in Surgery Partners by 0.3% during the first quarter. Bank of New York Mellon Corp now owns 341,702 shares of the company’s stock valued at $8,115,000 after acquiring an additional 926 shares during the period. Empowered Funds LLC boosted its holdings in Surgery Partners by 11.0% during the first quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock valued at $305,000 after acquiring an additional 1,278 shares during the period. Finally, Summit Securities Group LLC acquired a new stake in shares of Surgery Partners in the first quarter valued at about $31,000.

Insider Activity at Surgery Partners

In related news, Director Teresa Deluca sold 20,018 shares of the company’s stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the sale, the director owned 45,173 shares of the company’s stock, valued at approximately $1,027,234.02. This represents a 30.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Harrison R. Bane sold 9,339 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the completion of the sale, the insider owned 117,181 shares in the company, valued at $2,634,228.88. This represents a 7.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 2.70% of the stock is currently owned by insiders.

Surgery Partners Stock Performance

NASDAQ:SGRY opened at $21.50 on Friday. The business’s fifty day moving average is $21.62 and its 200 day moving average is $22.16. The firm has a market cap of $2.76 billion, a price-to-earnings ratio of -15.03 and a beta of 1.85. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93. Surgery Partners, Inc. has a 52-week low of $18.87 and a 52-week high of $31.89.

Surgery Partners (NASDAQ:SGRY) last posted its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The business had revenue of $826.20 million during the quarter, compared to analyst estimates of $816.96 million. During the same quarter in the previous year, the firm earned $0.21 EPS. The company’s quarterly revenue was up 8.4% compared to the same quarter last year. Research analysts predict that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Analyst Ratings Changes

Several equities analysts recently weighed in on SGRY shares. Bank of America assumed coverage on Surgery Partners in a research report on Monday, July 28th. They set a “buy” rating and a $28.00 price objective for the company. JPMorgan Chase & Co. started coverage on Surgery Partners in a research report on Thursday, September 18th. They issued a “neutral” rating and a $27.00 price target on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Surgery Partners in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $36.00 price objective on shares of Surgery Partners in a research report on Tuesday, October 7th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Surgery Partners presently has an average rating of “Moderate Buy” and an average target price of $31.14.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.